Janssen Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Sep 30, 2019 | 7 | Patent/Trademark Report to Commissioner (1) |
Sep 30, 2019 | 7 | Notice of Dismissal (1) |
Sep 30, 2019 | 7 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,439,906 B2. (Attachments: # (1) Notice of Dismissal)(fms) |
Sep 27, 2019 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [6]. (fms) |
Sep 27, 2019 | 6 | Notice of Voluntary Dismissal (1) Docket Text: NOTICE of Voluntary Dismissal by Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. as to Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Mylan Institutional LLC (without prejudice) (Blumenfeld, Jack) |
Aug 14, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nmg) |
Aug 9, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Mylan Institutional LLC on 8/9/2019; Mylan Laboratories Limited on 8/9/2019; Mylan Pharmaceuticals Inc. on 8/9/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sam) |
Aug 9, 2019 | 1 | Complaint (15) |
Aug 9, 2019 | 1 | Exhibit A (25) |
Aug 9, 2019 | 1 | Civil Cover Sheet (1) |
Aug 9, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
Aug 9, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: July 2, 2019. Date of Expiration of Patent: January 26, 2031.Thirty Month Stay Deadline: 1/2/2022. (sam) |
Aug 9, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,439,906 B2. (sam) |
Aug 9, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceutica NV, Janssen Pharmaceuticals, Inc. (sam) |
Aug 9, 2019 | 1 | Main Document (15) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Institutional LLC, Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2705242.) - filed by Janssen Pharmaceuticals, Inc., Janssen Pharmaceutica NV. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(sam) |
Aug 9, 2019 | 1 | Complaint* (1) |